RAXTOZINAMERAN: 47 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
47
Total FAERS Reports
2 (4.3%)
Deaths Reported
14
Hospitalizations
47
As Primary/Secondary Suspect
1
Life-Threatening
2
Disabilities
First Report: 20230101 · Latest Report: 20250127
What Are the Most Common RAXTOZINAMERAN Side Effects?
#1 Most Reported
Device breakage
9 reports (19.1%)
#2 Most Reported
Polyarthritis
6 reports (12.8%)
#3 Most Reported
Syringe issue
5 reports (10.6%)
All RAXTOZINAMERAN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Device breakage | 9 | 19.2% | 0 | 0 |
| Polyarthritis | 6 | 12.8% | 0 | 6 |
| Syringe issue | 5 | 10.6% | 0 | 0 |
Who Reports RAXTOZINAMERAN Side Effects? Age & Gender Data
Gender: 60.7% female, 39.3% male. Average age: 71.1 years. Most reports from: JP. View detailed demographics →
Is RAXTOZINAMERAN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2023 | 12 | 2 | 5 |
| 2024 | 27 | 0 | 7 |
| 2025 | 1 | 0 | 0 |
What Is RAXTOZINAMERAN Used For?
| Indication | Reports |
|---|---|
| Covid-19 immunisation | 43 |
Official FDA Label for RAXTOZINAMERAN
Official prescribing information from the FDA-approved drug label.